 Pamela Peterson
Concepts (431)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Failure | 71 | 2025 | 2236 | 5.970 |
Why?
| | Defibrillators, Implantable | 30 | 2022 | 315 | 4.660 |
Why?
| | Cardiac Resynchronization Therapy | 9 | 2022 | 46 | 2.870 |
Why?
| | Registries | 46 | 2025 | 2035 | 2.340 |
Why?
| | Ventricular Dysfunction, Left | 13 | 2023 | 382 | 2.080 |
Why?
| | Sexual Dysfunction, Physiological | 4 | 2024 | 64 | 2.020 |
Why?
| | Death, Sudden, Cardiac | 15 | 2019 | 185 | 2.010 |
Why?
| | Stroke Volume | 27 | 2024 | 612 | 2.010 |
Why?
| | Hospitalization | 32 | 2024 | 2199 | 1.980 |
Why?
| | Cardiac Rehabilitation | 4 | 2025 | 37 | 1.960 |
Why?
| | Cardiovascular Diseases | 16 | 2025 | 2111 | 1.900 |
Why?
| | Bradycardia | 3 | 2021 | 55 | 1.830 |
Why?
| | Cancer Survivors | 5 | 2024 | 285 | 1.780 |
Why?
| | Atrial Fibrillation | 8 | 2022 | 388 | 1.690 |
Why?
| | Primary Prevention | 12 | 2019 | 196 | 1.660 |
Why?
| | Cardiology | 15 | 2022 | 274 | 1.650 |
Why?
| | American Heart Association | 18 | 2022 | 306 | 1.630 |
Why?
| | Operating Rooms | 2 | 2024 | 123 | 1.460 |
Why?
| | Aged | 97 | 2025 | 23961 | 1.280 |
Why?
| | United States | 77 | 2025 | 14841 | 1.230 |
Why?
| | Patient Compliance | 5 | 2025 | 581 | 1.220 |
Why?
| | Cardiac Conduction System Disease | 2 | 2018 | 3 | 1.210 |
Why?
| | Patient Protection and Affordable Care Act | 2 | 2021 | 103 | 1.190 |
Why?
| | Medicare | 20 | 2024 | 773 | 1.180 |
Why?
| | Myocardial Infarction | 19 | 2018 | 1046 | 1.150 |
Why?
| | Cardiac Pacing, Artificial | 2 | 2018 | 87 | 1.150 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 10 | 2023 | 201 | 1.150 |
Why?
| | Patient Readmission | 11 | 2024 | 697 | 1.130 |
Why?
| | Practice Guidelines as Topic | 17 | 2019 | 1587 | 1.120 |
Why?
| | Healthcare Disparities | 7 | 2021 | 654 | 1.110 |
Why?
| | Humans | 168 | 2025 | 137585 | 1.060 |
Why?
| | Disposable Equipment | 2 | 2024 | 19 | 1.060 |
Why?
| | Adrenergic beta-Antagonists | 10 | 2023 | 323 | 0.960 |
Why?
| | Guideline Adherence | 12 | 2019 | 556 | 0.920 |
Why?
| | Male | 104 | 2025 | 67762 | 0.900 |
Why?
| | Female | 106 | 2025 | 73304 | 0.880 |
Why?
| | Reminder Systems | 3 | 2025 | 169 | 0.880 |
Why?
| | Practice Patterns, Physicians' | 11 | 2020 | 1313 | 0.860 |
Why?
| | Surgeons | 3 | 2022 | 297 | 0.850 |
Why?
| | Ventricular Function, Left | 7 | 2021 | 534 | 0.830 |
Why?
| | Secondary Prevention | 6 | 2017 | 233 | 0.780 |
Why?
| | Patient Discharge | 16 | 2024 | 897 | 0.780 |
Why?
| | Home Care Services | 2 | 2025 | 257 | 0.780 |
Why?
| | Aged, 80 and over | 40 | 2024 | 7635 | 0.780 |
Why?
| | Behavior Therapy | 1 | 2025 | 264 | 0.770 |
Why?
| | Angioplasty, Balloon | 1 | 2023 | 93 | 0.760 |
Why?
| | Health Status Disparities | 3 | 2021 | 289 | 0.740 |
Why?
| | Cardiac Resynchronization Therapy Devices | 3 | 2020 | 11 | 0.730 |
Why?
| | Middle Aged | 61 | 2025 | 33479 | 0.720 |
Why?
| | Anemia | 4 | 2020 | 170 | 0.700 |
Why?
| | Retrospective Studies | 36 | 2025 | 15657 | 0.700 |
Why?
| | Angiotensin Receptor Antagonists | 11 | 2023 | 92 | 0.690 |
Why?
| | Anti-Arrhythmia Agents | 4 | 2022 | 114 | 0.670 |
Why?
| | Peripheral Arterial Disease | 2 | 2024 | 475 | 0.630 |
Why?
| | Hospitals | 7 | 2021 | 691 | 0.600 |
Why?
| | Neoplasms | 5 | 2024 | 2671 | 0.590 |
Why?
| | Heart Block | 1 | 2018 | 42 | 0.590 |
Why?
| | Risk Factors | 30 | 2024 | 10388 | 0.580 |
Why?
| | Ventricular Function | 1 | 2018 | 61 | 0.580 |
Why?
| | Heart Failure, Diastolic | 1 | 2018 | 21 | 0.580 |
Why?
| | Heart Conduction System | 1 | 2018 | 99 | 0.570 |
Why?
| | Heart Failure, Systolic | 1 | 2018 | 25 | 0.570 |
Why?
| | Cardiologists | 1 | 2018 | 45 | 0.570 |
Why?
| | Birth Certificates | 1 | 2017 | 10 | 0.560 |
Why?
| | Stroke | 3 | 2024 | 1120 | 0.560 |
Why?
| | Risk Assessment | 15 | 2021 | 3457 | 0.550 |
Why?
| | Medicaid | 3 | 2021 | 435 | 0.550 |
Why?
| | Pregnancy Trimester, First | 1 | 2017 | 140 | 0.530 |
Why?
| | Congresses as Topic | 1 | 2018 | 233 | 0.530 |
Why?
| | Aminobutyrates | 6 | 2023 | 35 | 0.520 |
Why?
| | Clinical Decision-Making | 3 | 2018 | 322 | 0.520 |
Why?
| | Appointments and Schedules | 1 | 2017 | 89 | 0.520 |
Why?
| | Hospital Mortality | 8 | 2024 | 911 | 0.520 |
Why?
| | Medication Adherence | 6 | 2025 | 467 | 0.520 |
Why?
| | Decision Support Techniques | 5 | 2022 | 421 | 0.510 |
Why?
| | Text Messaging | 3 | 2025 | 157 | 0.500 |
Why?
| | Social Determinants of Health | 1 | 2020 | 267 | 0.500 |
Why?
| | Treatment Outcome | 27 | 2024 | 10811 | 0.490 |
Why?
| | Patient Outcome Assessment | 2 | 2021 | 131 | 0.480 |
Why?
| | Socioeconomic Factors | 1 | 2020 | 1289 | 0.470 |
Why?
| | Advisory Committees | 8 | 2022 | 219 | 0.470 |
Why?
| | Critical Care | 2 | 2018 | 601 | 0.460 |
Why?
| | Prenatal Care | 1 | 2017 | 294 | 0.460 |
Why?
| | Age Factors | 11 | 2020 | 3295 | 0.460 |
Why?
| | Outpatients | 4 | 2021 | 396 | 0.450 |
Why?
| | Patient Participation | 4 | 2022 | 420 | 0.450 |
Why?
| | Quality of Health Care | 6 | 2012 | 642 | 0.450 |
Why?
| | Waiting Lists | 1 | 2017 | 266 | 0.450 |
Why?
| | Cohort Studies | 21 | 2019 | 5742 | 0.440 |
Why?
| | Decision Making | 7 | 2022 | 900 | 0.440 |
Why?
| | Health Status Indicators | 3 | 2015 | 171 | 0.430 |
Why?
| | Hemoglobins | 3 | 2020 | 353 | 0.430 |
Why?
| | Cardiovascular Agents | 3 | 2025 | 159 | 0.430 |
Why?
| | Electrocardiography | 7 | 2021 | 629 | 0.420 |
Why?
| | Insurance Coverage | 3 | 2021 | 230 | 0.410 |
Why?
| | Heart | 4 | 2023 | 655 | 0.400 |
Why?
| | Health Literacy | 2 | 2014 | 168 | 0.400 |
Why?
| | Electric Countershock | 3 | 2019 | 107 | 0.380 |
Why?
| | Heart-Assist Devices | 1 | 2018 | 552 | 0.380 |
Why?
| | Time Factors | 16 | 2024 | 6828 | 0.370 |
Why?
| | Stress, Psychological | 1 | 2020 | 1100 | 0.370 |
Why?
| | Acculturation | 1 | 2012 | 53 | 0.370 |
Why?
| | Diabetes Mellitus | 5 | 2023 | 1040 | 0.360 |
Why?
| | Glomerular Filtration Rate | 3 | 2024 | 746 | 0.360 |
Why?
| | Valsartan | 5 | 2022 | 29 | 0.360 |
Why?
| | Coronary Artery Disease | 3 | 2013 | 698 | 0.360 |
Why?
| | Minority Groups | 2 | 2021 | 266 | 0.360 |
Why?
| | Health Status | 6 | 2012 | 792 | 0.360 |
Why?
| | Inpatients | 3 | 2023 | 500 | 0.350 |
Why?
| | Quality of Life | 13 | 2024 | 2892 | 0.350 |
Why?
| | Biphenyl Compounds | 5 | 2022 | 63 | 0.350 |
Why?
| | Tetrazoles | 5 | 2023 | 41 | 0.340 |
Why?
| | Coronary Disease | 3 | 2008 | 385 | 0.340 |
Why?
| | Arrhythmias, Cardiac | 3 | 2019 | 333 | 0.330 |
Why?
| | Heart Transplantation | 1 | 2017 | 754 | 0.330 |
Why?
| | Health Services Accessibility | 1 | 2017 | 986 | 0.320 |
Why?
| | Hospitals, Pediatric | 2 | 2024 | 508 | 0.320 |
Why?
| | Young Adult | 9 | 2024 | 13209 | 0.300 |
Why?
| | Metformin | 2 | 2023 | 331 | 0.300 |
Why?
| | Sex Factors | 8 | 2018 | 2071 | 0.300 |
Why?
| | Catheter Ablation | 1 | 2012 | 350 | 0.290 |
Why?
| | Physician-Patient Relations | 4 | 2021 | 548 | 0.280 |
Why?
| | Neprilysin | 4 | 2021 | 47 | 0.270 |
Why?
| | Renal Insufficiency, Chronic | 3 | 2023 | 617 | 0.260 |
Why?
| | Equipment Design | 4 | 2017 | 522 | 0.260 |
Why?
| | Quality Improvement | 4 | 2021 | 1178 | 0.260 |
Why?
| | Aftercare | 6 | 2023 | 208 | 0.250 |
Why?
| | Survivors | 2 | 2009 | 493 | 0.250 |
Why?
| | Ventricular Remodeling | 2 | 2018 | 266 | 0.250 |
Why?
| | Adult | 23 | 2024 | 37929 | 0.250 |
Why?
| | Ambulatory Care | 2 | 2025 | 546 | 0.250 |
Why?
| | Follow-Up Studies | 13 | 2021 | 5131 | 0.240 |
Why?
| | Cross-Sectional Studies | 11 | 2022 | 5472 | 0.240 |
Why?
| | Exercise Tolerance | 1 | 2008 | 279 | 0.240 |
Why?
| | Mineralocorticoid Receptor Antagonists | 3 | 2020 | 54 | 0.240 |
Why?
| | Social Support | 5 | 2014 | 618 | 0.230 |
Why?
| | Kidney Diseases | 1 | 2009 | 408 | 0.230 |
Why?
| | Self Care | 4 | 2018 | 380 | 0.230 |
Why?
| | Prone Position | 1 | 2005 | 30 | 0.230 |
Why?
| | Hydroxymethylglutaryl-CoA Reductase Inhibitors | 3 | 2024 | 445 | 0.230 |
Why?
| | Supine Position | 1 | 2005 | 39 | 0.230 |
Why?
| | Exercise Test | 4 | 2008 | 625 | 0.230 |
Why?
| | Diabetes Complications | 1 | 2006 | 227 | 0.230 |
Why?
| | Informed Consent | 2 | 2023 | 175 | 0.230 |
Why?
| | Atherosclerosis | 2 | 2024 | 415 | 0.230 |
Why?
| | Insurance, Health | 2 | 2017 | 283 | 0.230 |
Why?
| | Postoperative Complications | 2 | 2024 | 2654 | 0.220 |
Why?
| | Child | 7 | 2024 | 21935 | 0.220 |
Why?
| | Heart Diseases | 1 | 2008 | 346 | 0.220 |
Why?
| | Artifacts | 1 | 2005 | 129 | 0.220 |
Why?
| | Evidence-Based Medicine | 4 | 2013 | 740 | 0.220 |
Why?
| | Survival Analysis | 6 | 2019 | 1325 | 0.220 |
Why?
| | Quality Assurance, Health Care | 4 | 2010 | 322 | 0.220 |
Why?
| | Cardiovascular Abnormalities | 1 | 2024 | 13 | 0.220 |
Why?
| | Survival Rate | 7 | 2019 | 1972 | 0.210 |
Why?
| | Image Enhancement | 1 | 2005 | 190 | 0.210 |
Why?
| | Sex Characteristics | 1 | 2009 | 762 | 0.210 |
Why?
| | Qualitative Research | 3 | 2021 | 1386 | 0.210 |
Why?
| | Angiotensin II Type 1 Receptor Blockers | 2 | 2021 | 38 | 0.210 |
Why?
| | Odds Ratio | 7 | 2017 | 1070 | 0.210 |
Why?
| | Fee-for-Service Plans | 2 | 2014 | 88 | 0.210 |
Why?
| | Adolescent | 7 | 2024 | 21513 | 0.210 |
Why?
| | Drug Combinations | 5 | 2022 | 343 | 0.210 |
Why?
| | Predictive Value of Tests | 7 | 2018 | 2031 | 0.200 |
Why?
| | Depression | 7 | 2024 | 1397 | 0.200 |
Why?
| | Heart Rate | 3 | 2019 | 822 | 0.200 |
Why?
| | Risk | 3 | 2019 | 912 | 0.200 |
Why?
| | Incidence | 6 | 2019 | 2804 | 0.200 |
Why?
| | Atherectomy | 1 | 2023 | 37 | 0.200 |
Why?
| | Multicenter Studies as Topic | 2 | 2024 | 310 | 0.200 |
Why?
| | Vascular Patency | 1 | 2023 | 106 | 0.200 |
Why?
| | Popliteal Artery | 1 | 2023 | 59 | 0.200 |
Why?
| | Movement | 1 | 2005 | 278 | 0.200 |
Why?
| | Coated Materials, Biocompatible | 1 | 2023 | 62 | 0.200 |
Why?
| | Pneumatosis Cystoides Intestinalis | 1 | 2022 | 21 | 0.190 |
Why?
| | Randomized Controlled Trials as Topic | 4 | 2020 | 1477 | 0.190 |
Why?
| | Diabetes Mellitus, Type 2 | 4 | 2025 | 2531 | 0.190 |
Why?
| | Social Class | 2 | 2017 | 282 | 0.190 |
Why?
| | Mortality | 4 | 2017 | 362 | 0.190 |
Why?
| | Refusal to Participate | 1 | 2021 | 6 | 0.190 |
Why?
| | Colorado | 6 | 2017 | 4565 | 0.190 |
Why?
| | Prognosis | 9 | 2022 | 4030 | 0.190 |
Why?
| | Cardiac Surgical Procedures | 4 | 2010 | 530 | 0.190 |
Why?
| | Acute Kidney Injury | 2 | 2024 | 815 | 0.190 |
Why?
| | Seasons | 1 | 2024 | 547 | 0.190 |
Why?
| | Adenoidectomy | 1 | 2022 | 72 | 0.180 |
Why?
| | Multivariate Analysis | 11 | 2017 | 1509 | 0.180 |
Why?
| | Femoral Artery | 1 | 2023 | 179 | 0.180 |
Why?
| | Linear Models | 5 | 2017 | 849 | 0.180 |
Why?
| | Hospital Costs | 1 | 2022 | 117 | 0.180 |
Why?
| | Longitudinal Studies | 5 | 2018 | 2844 | 0.180 |
Why?
| | Electrocardiography, Ambulatory | 1 | 2021 | 63 | 0.180 |
Why?
| | Surgical Procedures, Operative | 1 | 2024 | 259 | 0.180 |
Why?
| | Hydroxychloroquine | 1 | 2021 | 58 | 0.180 |
Why?
| | Societies, Medical | 4 | 2020 | 820 | 0.170 |
Why?
| | Manufacturing Industry | 1 | 2020 | 4 | 0.170 |
Why?
| | Intestinal Obstruction | 1 | 2021 | 51 | 0.170 |
Why?
| | Surveys and Questionnaires | 10 | 2022 | 5778 | 0.170 |
Why?
| | Chi-Square Distribution | 5 | 2017 | 530 | 0.170 |
Why?
| | Patient Reported Outcome Measures | 2 | 2024 | 402 | 0.170 |
Why?
| | Interrupted Time Series Analysis | 1 | 2021 | 68 | 0.170 |
Why?
| | Comorbidity | 7 | 2023 | 1622 | 0.170 |
Why?
| | Protease Inhibitors | 1 | 2021 | 107 | 0.170 |
Why?
| | Groundwater | 1 | 2021 | 40 | 0.170 |
Why?
| | Health Care Costs | 1 | 2024 | 398 | 0.170 |
Why?
| | Patient Care | 1 | 2021 | 111 | 0.170 |
Why?
| | Prosthesis Implantation | 2 | 2019 | 153 | 0.170 |
Why?
| | Clinical Trials as Topic | 4 | 2015 | 1050 | 0.170 |
Why?
| | Goals | 2 | 2020 | 170 | 0.170 |
Why?
| | Exercise | 3 | 2009 | 2057 | 0.170 |
Why?
| | Confidence Intervals | 2 | 2012 | 329 | 0.160 |
Why?
| | Prospective Studies | 11 | 2018 | 7604 | 0.160 |
Why?
| | Research Personnel | 1 | 2021 | 173 | 0.160 |
Why?
| | Intensive Care Units | 2 | 2018 | 827 | 0.160 |
Why?
| | Algorithms | 2 | 2021 | 1704 | 0.160 |
Why?
| | Organizational Innovation | 1 | 2020 | 140 | 0.160 |
Why?
| | Income | 1 | 2020 | 202 | 0.160 |
Why?
| | Point-of-Care Systems | 1 | 2021 | 167 | 0.160 |
Why?
| | Health Behavior | 1 | 2025 | 762 | 0.160 |
Why?
| | Schools, Medical | 1 | 2020 | 147 | 0.160 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2020 | 58 | 0.160 |
Why?
| | Length of Stay | 3 | 2024 | 1215 | 0.150 |
Why?
| | Logistic Models | 7 | 2015 | 2074 | 0.150 |
Why?
| | Antirheumatic Agents | 1 | 2021 | 293 | 0.150 |
Why?
| | Multimorbidity | 1 | 2019 | 47 | 0.150 |
Why?
| | Hypertension | 3 | 2021 | 1295 | 0.150 |
Why?
| | Personal Satisfaction | 1 | 2020 | 207 | 0.150 |
Why?
| | Fraud | 1 | 2018 | 9 | 0.150 |
Why?
| | Medical Overuse | 1 | 2018 | 30 | 0.140 |
Why?
| | Minority Health | 1 | 2018 | 20 | 0.140 |
Why?
| | Hospitals, Rural | 1 | 2018 | 39 | 0.140 |
Why?
| | Research Design | 2 | 2023 | 1139 | 0.140 |
Why?
| | Computers, Handheld | 1 | 2018 | 25 | 0.140 |
Why?
| | Social Values | 1 | 2018 | 36 | 0.140 |
Why?
| | Patient Selection | 4 | 2021 | 696 | 0.140 |
Why?
| | Hospitals, Urban | 1 | 2018 | 134 | 0.140 |
Why?
| | Subacute Care | 1 | 2018 | 79 | 0.140 |
Why?
| | Bundle-Branch Block | 2 | 2017 | 31 | 0.140 |
Why?
| | Burns | 1 | 2022 | 325 | 0.140 |
Why?
| | Efficiency, Organizational | 1 | 2018 | 140 | 0.140 |
Why?
| | Treatment Refusal | 2 | 2008 | 89 | 0.140 |
Why?
| | Faculty, Medical | 1 | 2020 | 283 | 0.140 |
Why?
| | Coronary Angiography | 3 | 2008 | 317 | 0.130 |
Why?
| | Cause of Death | 3 | 2019 | 434 | 0.130 |
Why?
| | Thromboembolism | 1 | 2017 | 119 | 0.130 |
Why?
| | Early Detection of Cancer | 1 | 2021 | 447 | 0.130 |
Why?
| | Warfarin | 1 | 2017 | 154 | 0.130 |
Why?
| | Prosthesis Design | 1 | 2018 | 327 | 0.130 |
Why?
| | Medically Uninsured | 1 | 2017 | 130 | 0.120 |
Why?
| | Publishing | 1 | 2018 | 147 | 0.120 |
Why?
| | Prevalence | 5 | 2022 | 2734 | 0.120 |
Why?
| | Proportional Hazards Models | 4 | 2019 | 1266 | 0.120 |
Why?
| | Nurse Practitioners | 1 | 2018 | 138 | 0.120 |
Why?
| | Quality Indicators, Health Care | 1 | 2018 | 307 | 0.120 |
Why?
| | Racism | 1 | 2018 | 135 | 0.120 |
Why?
| | Percutaneous Coronary Intervention | 1 | 2021 | 480 | 0.120 |
Why?
| | Delivery of Health Care, Integrated | 1 | 2018 | 261 | 0.120 |
Why?
| | Health Policy | 1 | 2017 | 388 | 0.110 |
Why?
| | Attitude of Health Personnel | 2 | 2021 | 1171 | 0.110 |
Why?
| | Hyperkalemia | 1 | 2013 | 24 | 0.100 |
Why?
| | Mental Health | 1 | 2020 | 726 | 0.100 |
Why?
| | Health Knowledge, Attitudes, Practice | 2 | 2020 | 1329 | 0.100 |
Why?
| | Heart Ventricles | 1 | 2018 | 788 | 0.100 |
Why?
| | Systole | 2 | 2013 | 189 | 0.100 |
Why?
| | Cardiotonic Agents | 1 | 2014 | 124 | 0.100 |
Why?
| | Kidney | 1 | 2021 | 1468 | 0.100 |
Why?
| | Hemodialysis Units, Hospital | 1 | 2012 | 5 | 0.100 |
Why?
| | Severity of Illness Index | 3 | 2010 | 2828 | 0.100 |
Why?
| | Vascular Access Devices | 1 | 2012 | 26 | 0.100 |
Why?
| | Software | 1 | 2018 | 665 | 0.100 |
Why?
| | Infant | 2 | 2024 | 9465 | 0.100 |
Why?
| | Medical Staff | 1 | 2012 | 16 | 0.100 |
Why?
| | Anticoagulants | 1 | 2017 | 664 | 0.100 |
Why?
| | Consensus | 3 | 2022 | 683 | 0.100 |
Why?
| | Models, Educational | 1 | 2012 | 93 | 0.090 |
Why?
| | Child, Preschool | 2 | 2024 | 11074 | 0.090 |
Why?
| | Kaplan-Meier Estimate | 2 | 2016 | 889 | 0.090 |
Why?
| | Communication | 1 | 2018 | 879 | 0.090 |
Why?
| | Physicians | 1 | 2020 | 910 | 0.090 |
Why?
| | Antihypertensive Agents | 2 | 2023 | 494 | 0.090 |
Why?
| | Drug Prescriptions | 1 | 2013 | 245 | 0.090 |
Why?
| | Angina Pectoris | 2 | 2010 | 65 | 0.090 |
Why?
| | Forecasting | 2 | 2024 | 389 | 0.090 |
Why?
| | Evidence-Based Practice | 2 | 2013 | 229 | 0.090 |
Why?
| | Vocabulary | 1 | 2011 | 38 | 0.090 |
Why?
| | Peripheral Vascular Diseases | 1 | 2011 | 103 | 0.090 |
Why?
| | Ambulatory Care Facilities | 1 | 2012 | 232 | 0.090 |
Why?
| | Managed Care Programs | 1 | 2011 | 135 | 0.080 |
Why?
| | Contraindications | 1 | 2010 | 90 | 0.080 |
Why?
| | Pilot Projects | 3 | 2021 | 1710 | 0.080 |
Why?
| | Bacteremia | 1 | 2012 | 214 | 0.080 |
Why?
| | Renin-Angiotensin System | 2 | 2023 | 85 | 0.080 |
Why?
| | Women's Health Services | 1 | 2010 | 16 | 0.080 |
Why?
| | Patient-Centered Care | 1 | 2015 | 530 | 0.080 |
Why?
| | Cooperative Behavior | 1 | 2012 | 451 | 0.080 |
Why?
| | Diuretics | 2 | 2020 | 74 | 0.080 |
Why?
| | Reproducibility of Results | 2 | 2009 | 3284 | 0.080 |
Why?
| | Palliative Care | 2 | 2019 | 758 | 0.080 |
Why?
| | Probability | 1 | 2010 | 304 | 0.080 |
Why?
| | ROC Curve | 1 | 2009 | 554 | 0.070 |
Why?
| | Coronary Care Units | 1 | 2007 | 19 | 0.070 |
Why?
| | Myocardial Reperfusion | 1 | 2007 | 50 | 0.070 |
Why?
| | Chest Pain | 1 | 2007 | 91 | 0.070 |
Why?
| | Women's Health | 1 | 2010 | 372 | 0.070 |
Why?
| | Emergency Service, Hospital | 2 | 2010 | 2069 | 0.070 |
Why?
| | Emotions | 1 | 2012 | 548 | 0.070 |
Why?
| | Myocardial Ischemia | 2 | 2019 | 263 | 0.070 |
Why?
| | Research Report | 2 | 2017 | 83 | 0.060 |
Why?
| | Caregivers | 1 | 2014 | 877 | 0.060 |
Why?
| | Angina, Unstable | 1 | 2006 | 76 | 0.060 |
Why?
| | Health Personnel | 1 | 2012 | 710 | 0.060 |
Why?
| | Syndrome | 1 | 2006 | 358 | 0.060 |
Why?
| | Cardiac Output, Low | 1 | 2006 | 66 | 0.060 |
Why?
| | Renal Dialysis | 2 | 2024 | 435 | 0.060 |
Why?
| | Weight Loss | 2 | 2009 | 787 | 0.060 |
Why?
| | Diagnostic Errors | 1 | 2006 | 170 | 0.060 |
Why?
| | Sickness Impact Profile | 1 | 2005 | 56 | 0.060 |
Why?
| | Physical Endurance | 1 | 2006 | 275 | 0.060 |
Why?
| | Heart Valves | 1 | 2005 | 43 | 0.060 |
Why?
| | Radionuclide Imaging | 1 | 2005 | 118 | 0.060 |
Why?
| | Pregnancy | 1 | 2017 | 6763 | 0.060 |
Why?
| | New York | 1 | 2024 | 126 | 0.060 |
Why?
| | Recovery of Function | 1 | 2008 | 653 | 0.060 |
Why?
| | Depressive Disorder | 1 | 2007 | 379 | 0.050 |
Why?
| | Weight Gain | 1 | 2007 | 519 | 0.050 |
Why?
| | Acute Disease | 1 | 2006 | 1007 | 0.050 |
Why?
| | Electronic Health Records | 1 | 2011 | 1069 | 0.050 |
Why?
| | Overweight | 1 | 2007 | 558 | 0.050 |
Why?
| | Image Interpretation, Computer-Assisted | 1 | 2005 | 267 | 0.050 |
Why?
| | Patients | 1 | 2024 | 175 | 0.050 |
Why?
| | Sodium | 1 | 2023 | 217 | 0.050 |
Why?
| | Biomedical Research | 1 | 2008 | 692 | 0.050 |
Why?
| | Pragmatic Clinical Trials as Topic | 1 | 2021 | 65 | 0.050 |
Why?
| | Adhesives | 1 | 2021 | 14 | 0.050 |
Why?
| | Tissue Adhesions | 1 | 2021 | 32 | 0.050 |
Why?
| | Medical Oncology | 1 | 2024 | 289 | 0.040 |
Why?
| | Population Health | 1 | 2021 | 47 | 0.040 |
Why?
| | Disease Management | 2 | 2017 | 628 | 0.040 |
Why?
| | Trust | 1 | 2021 | 127 | 0.040 |
Why?
| | Health Services Misuse | 1 | 2020 | 33 | 0.040 |
Why?
| | Transferrins | 1 | 2020 | 1 | 0.040 |
Why?
| | Transferrin | 1 | 2020 | 47 | 0.040 |
Why?
| | Ferritins | 1 | 2020 | 64 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2005 | 1946 | 0.040 |
Why?
| | Educational Status | 1 | 2022 | 470 | 0.040 |
Why?
| | Intestines | 1 | 2022 | 357 | 0.040 |
Why?
| | Morbidity | 1 | 2020 | 324 | 0.040 |
Why?
| | Patient Safety | 2 | 2012 | 314 | 0.040 |
Why?
| | United States Government Agencies | 1 | 2018 | 5 | 0.040 |
Why?
| | Cost-Benefit Analysis | 1 | 2021 | 591 | 0.040 |
Why?
| | Health Care Surveys | 2 | 2010 | 565 | 0.040 |
Why?
| | Cardiovascular Nursing | 1 | 2018 | 3 | 0.040 |
Why?
| | Transitional Care | 1 | 2018 | 41 | 0.040 |
Why?
| | Aspirin | 2 | 2015 | 387 | 0.040 |
Why?
| | Glucose | 1 | 2023 | 1020 | 0.040 |
Why?
| | F Factor | 1 | 2017 | 3 | 0.030 |
Why?
| | Tachycardia, Ventricular | 1 | 2019 | 175 | 0.030 |
Why?
| | Health Facility Size | 1 | 2017 | 11 | 0.030 |
Why?
| | Focus Groups | 1 | 2020 | 522 | 0.030 |
Why?
| | Continuity of Patient Care | 1 | 2019 | 284 | 0.030 |
Why?
| | Sex Distribution | 1 | 2017 | 375 | 0.030 |
Why?
| | Hospitals, Teaching | 1 | 2017 | 118 | 0.030 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2014 | 2057 | 0.030 |
Why?
| | Cerebrovascular Disorders | 1 | 2017 | 96 | 0.030 |
Why?
| | Exercise Therapy | 1 | 2020 | 443 | 0.030 |
Why?
| | Biomarkers | 2 | 2017 | 4149 | 0.030 |
Why?
| | Mass Screening | 1 | 2024 | 1287 | 0.030 |
Why?
| | Information Dissemination | 1 | 2018 | 218 | 0.030 |
Why?
| | Skilled Nursing Facilities | 1 | 2017 | 141 | 0.030 |
Why?
| | Administration, Oral | 1 | 2017 | 816 | 0.030 |
Why?
| | Frail Elderly | 1 | 2015 | 131 | 0.030 |
Why?
| | Regression Analysis | 1 | 2017 | 1024 | 0.030 |
Why?
| | Chronic Disease | 1 | 2020 | 1793 | 0.030 |
Why?
| | Hypoglycemic Agents | 1 | 2023 | 1291 | 0.030 |
Why?
| | Patient Satisfaction | 1 | 2018 | 660 | 0.030 |
Why?
| | Liver Cirrhosis | 1 | 2015 | 316 | 0.030 |
Why?
| | Potassium | 1 | 2013 | 147 | 0.030 |
Why?
| | Comparative Effectiveness Research | 1 | 2014 | 152 | 0.030 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2010 | 3715 | 0.030 |
Why?
| | Pandemics | 1 | 2022 | 1639 | 0.030 |
Why?
| | Infusions, Intravenous | 1 | 2014 | 413 | 0.020 |
Why?
| | Databases, Factual | 1 | 2018 | 1357 | 0.020 |
Why?
| | Hemorrhage | 1 | 2017 | 722 | 0.020 |
Why?
| | Pacific States | 1 | 2012 | 6 | 0.020 |
Why?
| | Propensity Score | 1 | 2014 | 294 | 0.020 |
Why?
| | New England | 1 | 2012 | 32 | 0.020 |
Why?
| | Drug Utilization Review | 1 | 2012 | 57 | 0.020 |
Why?
| | Anti-Bacterial Agents | 1 | 2022 | 1809 | 0.020 |
Why?
| | Health Maintenance Organizations | 1 | 2012 | 108 | 0.020 |
Why?
| | Needs Assessment | 1 | 2014 | 376 | 0.020 |
Why?
| | Dementia | 1 | 2015 | 259 | 0.020 |
Why?
| | Education | 1 | 2012 | 108 | 0.020 |
Why?
| | Recurrence | 1 | 2015 | 1060 | 0.020 |
Why?
| | Creatinine | 1 | 2013 | 499 | 0.020 |
Why?
| | Internationality | 1 | 2012 | 155 | 0.020 |
Why?
| | Monitoring, Physiologic | 1 | 2013 | 275 | 0.020 |
Why?
| | History, 21st Century | 1 | 2012 | 213 | 0.020 |
Why?
| | Drug Utilization | 1 | 2012 | 169 | 0.020 |
Why?
| | Infection Control | 1 | 2012 | 167 | 0.020 |
Why?
| | History, 20th Century | 1 | 2012 | 325 | 0.020 |
Why?
| | Platelet Aggregation Inhibitors | 1 | 2015 | 463 | 0.020 |
Why?
| | Pacemaker, Artificial | 1 | 2012 | 119 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2012 | 499 | 0.020 |
Why?
| | Lung Diseases | 1 | 2017 | 767 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2021 | 6079 | 0.020 |
Why?
| | Poisson Distribution | 1 | 2010 | 75 | 0.020 |
Why?
| | Terminology as Topic | 1 | 2011 | 216 | 0.020 |
Why?
| | Eligibility Determination | 1 | 2009 | 65 | 0.020 |
Why?
| | Terminal Care | 1 | 2012 | 232 | 0.020 |
Why?
| | Myocardial Revascularization | 1 | 2008 | 73 | 0.020 |
Why?
| | Databases as Topic | 1 | 2007 | 67 | 0.020 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2015 | 1040 | 0.020 |
Why?
| | Blood Pressure Determination | 1 | 2008 | 157 | 0.020 |
Why?
| | Reperfusion | 1 | 2006 | 40 | 0.020 |
Why?
| | Sleep Wake Disorders | 1 | 2009 | 286 | 0.020 |
Why?
| | Cognition Disorders | 1 | 2009 | 496 | 0.010 |
Why?
| | California | 1 | 2006 | 431 | 0.010 |
Why?
| | Family | 1 | 2009 | 671 | 0.010 |
Why?
| | Referral and Consultation | 1 | 2010 | 786 | 0.010 |
Why?
| | Clinical Competence | 1 | 2012 | 1118 | 0.010 |
Why?
| | Interviews as Topic | 1 | 2007 | 786 | 0.010 |
Why?
| | Smoking Cessation | 1 | 2007 | 442 | 0.010 |
Why?
| | Coronary Artery Bypass | 1 | 2005 | 234 | 0.010 |
Why?
| | Alcohol Drinking | 1 | 2009 | 828 | 0.010 |
Why?
| | Delivery of Health Care | 1 | 2009 | 951 | 0.010 |
Why?
| | Anxiety | 1 | 2009 | 1035 | 0.010 |
Why?
| | Diet | 1 | 2009 | 1278 | 0.010 |
Why?
| | Blood Pressure | 1 | 2008 | 1786 | 0.010 |
Why?
| | Blood Glucose | 1 | 2010 | 2186 | 0.010 |
Why?
| | Body Mass Index | 1 | 2007 | 2389 | 0.010 |
Why?
| | Obesity | 1 | 2007 | 2992 | 0.010 |
Why?
|
|
Peterson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|